Literature DB >> 22337988

Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma.

Hart B Moss1, Sai Chavala, Emil Say, Melissa B Miller.   

Abstract

A patient with systemic cytomegalovirus (CMV), including chorioretinitis, received localized and systemic ganciclovir, systemic cidofovir analog, and localized foscarnet. Mutations conferring ganciclovir and cidofovir resistance were detected in CMV from the aqueous fluid but not in CMV from plasma. Quantifying CMV from aqueous fluid was valuable for monitoring the clinical response and predicting resistance.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22337988      PMCID： PMC3347158          DOI： 10.1128/JCM.00029-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.

Authors:  Sunwen Chou
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

2.  Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis.

Authors:  Mélanie Martin; Nathalie Goyette; Jane Ives; Guy Boivin
Journal:  J Clin Virol       Date:  2010-02-06       Impact factor: 3.168

Review 3.  Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV.

Authors:  M Arens
Journal:  J Clin Virol       Date:  2001-08       Impact factor: 3.168

4.  Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy.

Authors:  Sunwen Chou
Journal:  J Clin Virol       Date:  2011-02-03       Impact factor: 3.168

5.  Polymerase chain reaction-based ganciclovir resistance testing of ocular fluids for cytomegalovirus retinitis.

Authors:  Steven Yeh; Gary Fahle; Farzin Forooghian; Lisa J Faia; Eric D Weichel; J Timothy Stout; Christina J Flaxel; Andreas K Lauer; H Nida Sen; Robert B Nussenblatt
Journal:  Arch Ophthalmol       Date:  2012-01

Review 6.  Antiviral drug resistance of human cytomegalovirus.

Authors:  Nell S Lurain; Sunwen Chou
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  VZV retinal vasculitis without systemic infection: diagnosis and monitoring with quantitative Polymerase Chain Reaction.

Authors:  Yves Wimmersberger; A Gervaix; Edoardo Baglivo
Journal:  Int Ophthalmol       Date:  2008-10-14       Impact factor: 2.031

Review 8.  A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes.

Authors:  Meike Chevillotte; Jens von Einem; Benjamin M Meier; Feng-Mao Lin; Hans A Kestler; Thomas Mertens
Journal:  Antiviral Res       Date:  2009-10-22       Impact factor: 5.970

9.  Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA.

Authors:  Jason L Sanchez; Gregory A Storch
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

10.  Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome.

Authors:  Roger Wong; Carlos E Pavesio; D Alistair H Laidlaw; Tom H Williamson; Elizabeth M Graham; Miles R Stanford
Journal:  Ophthalmology       Date:  2009-12-23       Impact factor: 12.079
View more
  1 in total

1.  Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature.

Authors:  Kenneth M Downes; Dariusz Tarasewicz; Laurie J Weisberg; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.